Agency Forms Undergoing Paperwork Reduction Act Review, 12361-12362 [2023-03959]
Download as PDF
12361
Federal Register / Vol. 88, No. 38 / Monday, February 27, 2023 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Public Health Laboratories ...................
3b. Annual Evaluation and Performance Measurement Report for Bacterial Specimen Testing.
3c. Monthly Data Report Form for Bacterial Specimen Testing.
3d. AR Lab Network Alerts—Bacterial Specimen
Testing.
3e. Annual Evaluation and Performance Measurement Report (Candida identification).
3f. Monthly Data Report Form for Candida identification.
3g. AR Lab Network Alerts Report Form for
Candida auris.
3h. Annual Evaluation and Performance Measurement Report (Neisseria gonorrhoeae).
3i. AR Lab Network Alert and Monthly Data Report
Form for Neisseria gonorrhoeae.
3j. Annual Evaluation and Performance Measurement Report (C. auris Whole Genome Sequencing).
3k. AR Lab Network Form for Isolate/Specimenlevel Mycotics Testing (C. auris Whole Genome
Sequencing).
3l. AR Lab Network Form for Phylogenetic Treelevel Mycotics Reporting (C. auris Whole Genome Sequencing).
Public Health Laboratories ...................
Public Health Laboratories ...................
Public Health Laboratories ...................
Public Health Laboratories ...................
Public Health Laboratories ...................
Public Health Laboratories ...................
Public Health Laboratories ...................
Public Health Laboratories ...................
Public Health Laboratories ...................
Public Health Laboratories ...................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–03960 Filed 2–24–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–22FS]
Agency Forms Undergoing Paperwork
Reduction Act Review
ddrumheller on DSK120RN23PROD with NOTICES
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Artificial
Stone Countertops: Exposures, Controls,
Surveillance, & Translation’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on June 02, 2022 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
VerDate Sep<11>2014
20:06 Feb 24, 2023
Jkt 259001
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Average
number of
responses per
respondent
Average
burden per
response
(in hours)
56
1
4
56
12
4
56
34
6/60
56
1
2
56
12
2
56
13
6/60
56
1
1
56
12
6/60
56
1
1
56
12
6/60
56
12
6/60
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Artificial Stone Countertops:
Exposures, Controls, Surveillance, &
Translation—New—National Institute
for Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
As a recently introduced technology
in the United States, the Artificial Stone
(AS) Countertop industry is not well
defined; the obligation to monitor
workers’ health might not be known,
considered, or understood; and
education on potential hazard and
health risks related to respirable
crystalline silica (RCS) is limited.
Exposure is associated with the
development of silicosis, an irreversible,
sometimes fatal, but preventable lung
disease. Twenty-four cases of silicosis,
E:\FR\FM\27FEN1.SGM
27FEN1
12362
Federal Register / Vol. 88, No. 38 / Monday, February 27, 2023 / Notices
including two deaths, have been
reported among AS fabrication workers
in the United States. The anticipated
impacts of this project are increased
understanding of industry scale,
practices, and medical monitoring, and
increased collaboration and
communication to inform the AS
Countertop industry of industry
hazards, methods to mitigate exposure,
and improve medical surveillance.
Understanding how or if current RCS
recommendations and regulations are
used by various AS Countertop
fabrication facilities will identify
approaches for improved intervention.
The purpose of the proposed
collection is to conduct a survey with
AS Countertop fabrication facilities to
better understand: (1) work practices
and controls related to respirable
crystalline silica; (2) barriers or
facilitators to implementation of
medical and exposure monitoring
requirements; (3) identify areas for
potential intervention; and (4) identify
countertop fabrication facilities willing
to participate in future NIOSH exposure
and health research.
The estimate of burden hours is based
on an internal pilot test of the survey
instrument. The average time for
reviewing instructions, gathering mock
information, and completing the survey
was between 10–30 minutes. For the
purposes of estimating burden hours,
the median time to complete the survey
is used. An estimated 8,600 respondents
are anticipated to participate in the
survey. for 2,150 annual burden hours.
There are no costs to respondents other
than their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Facility Managers/Owners ..............................
Workplace Survey ..........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–03959 Filed 2–24–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–22HY]
Agency Forms Undergoing Paperwork
Reduction Act Review
ddrumheller on DSK120RN23PROD with NOTICES
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled, ‘‘Centralized
Institutional Review for the CDC
Expanded Access Investigational New
Device (EA–IND) for Use of Tecovirimat
(TPOXX®) for Treatment of Human
Non-Variola Orthopoxvirus Infections in
Adults and Children (IND 116039/CDC
#6402),’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on August
22, 2022, to obtain comments from the
public and affected agencies. CDC
received two comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
VerDate Sep<11>2014
20:06 Feb 24, 2023
Jkt 259001
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
8,600
Number of
responses per
respondent
1
Average
burden per
response
(in hours)
15/60
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Centralized Institutional Review for
the CDC Expanded Access
Investigational New Device (EA–IND)
for ‘‘Use of Tecovirimat (TPOXX®) for
Treatment of Human Non-Variola
Orthopoxvirus Infections in Adults and
Children’’ (IND 116039/CDC #6402)—
New—Office of Science (OS), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Monkeypox is a zoonosis, caused by
the Orthopoxvirus (OPXV) Monkeypox
virus (MPXV), and is endemic to
forested areas of West and Central
Africa. In humans, infection with MPXV
can lead to a smallpox-like illness with
fatal outcomes in up to 11% of patients
without prior smallpox vaccination.
Since May 2022, clusters of
monkeypox cases, have been reported in
19 countries that do not normally have
monkeypox, and the number of
confirmed cases in the U.S. is rapidly
increasing.
Tecovirimat (TPOXX) is FDAapproved for the treatment of human
smallpox disease caused by Variola
virus in adults and children. However,
its use for other orthopoxvirus
infections, including monkeypox, is not
approved by the FDA. CDC currently
holds a non-research expanded access
Investigational New Drug (EA–IND)
protocol that allows for the use of
tecovirimat for primary or early empiric
treatment of non-variola orthopoxvirus
E:\FR\FM\27FEN1.SGM
27FEN1
Agencies
[Federal Register Volume 88, Number 38 (Monday, February 27, 2023)]
[Notices]
[Pages 12361-12362]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03959]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-22FS]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Artificial Stone Countertops: Exposures,
Controls, Surveillance, & Translation'' to the Office of Management and
Budget (OMB) for review and approval. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on June 02, 2022 to obtain comments from the
public and affected agencies. CDC did not receive comments related to
the previous notice. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Artificial Stone Countertops: Exposures, Controls, Surveillance, &
Translation--New--National Institute for Occupational Safety and Health
(NIOSH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
As a recently introduced technology in the United States, the
Artificial Stone (AS) Countertop industry is not well defined; the
obligation to monitor workers' health might not be known, considered,
or understood; and education on potential hazard and health risks
related to respirable crystalline silica (RCS) is limited. Exposure is
associated with the development of silicosis, an irreversible,
sometimes fatal, but preventable lung disease. Twenty-four cases of
silicosis,
[[Page 12362]]
including two deaths, have been reported among AS fabrication workers
in the United States. The anticipated impacts of this project are
increased understanding of industry scale, practices, and medical
monitoring, and increased collaboration and communication to inform the
AS Countertop industry of industry hazards, methods to mitigate
exposure, and improve medical surveillance. Understanding how or if
current RCS recommendations and regulations are used by various AS
Countertop fabrication facilities will identify approaches for improved
intervention.
The purpose of the proposed collection is to conduct a survey with
AS Countertop fabrication facilities to better understand: (1) work
practices and controls related to respirable crystalline silica; (2)
barriers or facilitators to implementation of medical and exposure
monitoring requirements; (3) identify areas for potential intervention;
and (4) identify countertop fabrication facilities willing to
participate in future NIOSH exposure and health research.
The estimate of burden hours is based on an internal pilot test of
the survey instrument. The average time for reviewing instructions,
gathering mock information, and completing the survey was between 10-30
minutes. For the purposes of estimating burden hours, the median time
to complete the survey is used. An estimated 8,600 respondents are
anticipated to participate in the survey. for 2,150 annual burden
hours. There are no costs to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Facility Managers/Owners.............. Workplace Survey........ 8,600 1 15/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-03959 Filed 2-24-23; 8:45 am]
BILLING CODE 4163-18-P